PopeHGKeckPEMcElroySL. Frequency and presentation of neuroleptic malignant syndrome in a large psychiatric-hospital. Am J Psychiatry1986; 143: 1227–1233.
2.
Neuroleptic malignant syndrome diagnostic and statistical manual of mental disorders. 4th ed.Washington, DC: American Psychiatric Association, 1994, pp.739–742.
3.
StevensDL. Association between selective serotonin-reuptake inhibitors, second-generation antipsychotics, and neuroleptic malignant syndrome. Ann Pharmacother2008; 42: 1290–1297.
4.
VelamoorVRNormanRMCaroffSN, et al. Progression of symptoms in neuroleptic malignant syndrome. J NervMent Dis1994; 182: 168.
5.
PeirisDTKuruppuarachchiKWeerasenaLP, et al.Neuroleptic malignant syndrome without fever: a report of three cases. J Neurol Neurosurg Psychiatry2000; 69: 277–278.
6.
SinghaiKKuppiliPPNebhinaniN. Atypical neuroleptic malignant syndrome: a systematic review of case reports. Gen Hosp Psychiatry2019; 60: 12–19.
7.
LeversonJL. Neuroleptic malignant syndrome. Am J Psychiatry1985; 142: 1137–1145.